LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trialJean Bourhis, A. Aupérin, A. Coutte et al.|Annals of Oncology|2021Cited by 87
LBA39 3-years follow-up of double-blind randomized phase II comparing concurrent high-dose cisplatin chemo-radiation plus xevinapant or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neckJean Bourhis, Yunxia Tao, Xinghua Sun et al.|Annals of Oncology|2020Cited by 7
Double-blind randomized phase II results comparing concurrent high-dose cisplatin chemorradiation (CRT) plus debio 1143 or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN): A GORTEC studyJean Bourhis, Y. Tao, Xinghua Sun et al.|Annals of Oncology|2019Cited by 4